Efficacy and Safety of Topical Anticholinergics in the Treatment of Primary Axillary Hyperhidrosis: A Systematic Review and Meta-analysis
Clinical Drug Investigation · 2026-06 · 46 (6) · 583-594
DOI: 10.1007/s40261-026-01550-2 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical Drug Investigation, online erschienen am 16.04.2026. Verfasst von Jiah Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Kyungsung University, 309, Suyeong-ro, Nam-gu, Busan, 48434, Republic of Korea. Hauptthemen laut MEDLINE: Hyperhidrosis, Cholinergic Antagonists. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Ministry of Science and ICT, South Korea.
Abstract (Originalsprache)
BACKGROUND: Topical anticholinergic agents are non-invasive treatment options for primary axillary hyperhidrosis (PAH). Sofpironium bromide was recently approved by the US Food and Drug Administration (FDA). A comprehensive evaluation of the efficacy and safety of available topical anticholinergics may inform clinical practice. OBJECTIVES: To assess the efficacy and safety of topical anticholinergic therapies for PAH through systematic review and meta-analysis of randomized controlled trials (RCTs). METHODS: Five databases were searched on September 9, 2024. Primary outcomes included a ≥2-point improvement in the Hyperhidrosis Disease Severity Scale (HDSS) and ≥50% reduction in gravimetric sweat production (GSP). Secondary outcomes included subjective symptom improvement and objective sweat reduction. Safety outcomes included treatment-emergent adverse events (TEAEs), anticholinergic-related adverse events, and local application site reactions. The review protocol was registered in PROSPERO (CRD42024583376). RESULTS: Eight RCTs (n = 1921) that evaluated glycopyrronium, sofpironium bromide, and umeclidinium were included. Topical agents significantly outperformed placebos for HDSS ≥2-point improvement (risk ratio [RR]: 2.40; 95% confidence interval [CI]: 2.01-2.86) and GSP ≥50% reduction (RR: 1.43; 95% CI: 1.21-1.70). Sofpironium was the most effective HDSS treatment, whereas glycopyrronium showed highest efficacy against GSP. Topical agents were associated with increased risk of TEAEs (RR: 1.43; 95% CI: 1.14-1.79), with sofpironium associated with highest risk of dry mouth and glycopyrronium with highest risks for mydriasis and constipation. CONCLUSIONS: Topical anticholinergic agents are effective for PAH treatment, with distinct efficacy and safety profiles. Although the available evidence is limited by the small number of trials, short follow-up durations, and heterogeneity in outcome reporting, these findings support the role of topical anticholinergic therapy as an effective non-invasive option for PAH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Kyungsung University, 309, Suyeong-ro, Nam-gu, Busan, 48434, Republic of Korea.
- College of Pharmacy, Jeju National University, 102 Jejudaehak-ro, Jeju, 63241, Republic of Korea.
- Department of Food Science and Biotechnology, BB21plus Project Team, Kyungsung University, 309, Suyeong-ro, Nam-gu, Busan, 48434, Republic of Korea.
- Functional Food and Drug Convergence Research Center, Industry-Academic Cooperation Foundation, Kyungsung University, 309, Suyeong-ro, Nam-gu, Busan, 48434, Republic of Korea.
- Department of Pharmacy, Pusan National University Yangsan Hospital, 20, Geumo-ro, Mulgeum-eup, Yangsan-si, Gyeongsangnam-do, 50612, Republic of Korea.
- College of Pharmacy and Research Institute for Drug Development, Pusan National University, 63 Busandaehak-ro, Geumjeong-gu, Busan, 46241, Republic of Korea.
ORCID-Profile: Hyunji Koo
Förderung
- Ministry of Science and ICT, South Korea
Zitieren
APA
Kim, J., Han, N., Koo, H., Kim, Y., Hwang, E. J., Kim, M. S., Staatz, C. E., & Baek, I. H. (2026). Efficacy and Safety of Topical Anticholinergics in the Treatment of Primary Axillary Hyperhidrosis: A Systematic Review and Meta-analysis. Clinical Drug Investigation, 46(6), 583-594. https://doi.org/10.1007/s40261-026-01550-2
Vancouver
Kim J, Han N, Koo H, Kim Y, Hwang EJ, Kim MS, et al. Efficacy and Safety of Topical Anticholinergics in the Treatment of Primary Axillary Hyperhidrosis: A Systematic Review and Meta-analysis. Clinical Drug Investigation. 2026;46(6):583-594. doi:10.1007/s40261-026-01550-2
BibTeX
@article{Kim2026,
author = {Kim, Jiah and Han, Nayoung and Koo, Hyunji and Kim, Younghwa and Hwang, Eun Jung and Kim, Min-Soo and Staatz, Christine E and Baek, In-Hwan},
title = {Efficacy and Safety of Topical Anticholinergics in the Treatment of Primary Axillary Hyperhidrosis: A Systematic Review and Meta-analysis},
journal = {Clinical Drug Investigation},
year = {2026},
volume = {46},
number = {6},
pages = {583--594},
doi = {10.1007/s40261-026-01550-2}
}
EUVIMED